Further inquiry note: Branche: Pharmaceuticals ISIN: DE0007783003 WKN: 778300 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hamburg / regulated dealing ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 3-month report 08.11.2007 Berlin, 8th November 2007. The Marseille-Kliniken AG, (Prime Standard, ISIN DE 0007783003, MKA) has been able to improve its results in an above-average way. In the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. annual report 10.10.2007 Berlin, October 10., 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, and MKA) continues to grow and improves its result. On the basis of preliminary ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.06.2007 Berlin, June 29, 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) successfully closed a third substantial sale-and-lease-back transaction with real estate ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 08.05.2007 Berlin, 8th May 2007. During the first three quarters of the 2006/2007 fiscal year, Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) further enhanced ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.02.2007 Berlin, 8th February 2007. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has been able to further enhance its revenues in the first half-year period of the 2006/2007 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.11.2006 Berlin, 8th November 2006. The Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) continues improving its results in an above-average way. In the first quarter of the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.10.2006 Berlin, 27. October 2006. Marseille-Kliniken AG, (Prime Standard, ISIN DE 0007783003, MKA) will continue its shareholder-friendly dividend distribution policy this year thanks to the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.10.2006 Berlin, 20th October 2006. The Marseille-Kliniken AG, (Prime Standard, ISIN DE 0007783003, MKA) is continuing to grow and is recording above-average results. In the financial year of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.05.2006 Berlin, 9th May 2006. The first three quarters of the trading year 2005/2006 have brought an increase in revenue of 3.1% for the Marseille-Kliniken AG (Prime Standard, ISIN DE ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.02.2006 Berlin, 8th February 2006: The Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has been able to increase its turnover in the first half of the fiscal year 2005/06 by ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 06.12.2005 Berlin, 6th December 2005. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to successfully conclude after the GE deal a second substantial sale-and-leaseback ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 07.11.2005 Berlin, November 8, 2005 - Marseille-Kliniken AG (Prime Standard, ISIN DE0007783003, MKA) was able to increase its consolidated operating revenues from EUR 50.8 million to EUR 51.5 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 29.09.2005 Berlin, September 29, 2005 - On the basis of preliminary figures for the fiscal year 2004/05, the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to slightly ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.05.2005 In the first three quarters of the fiscal year 2004/05, the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to further increase sales by 1.2% to EUR 152.1 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 08.02.2005 In the first half of the fiscal year 2004/05, the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to slightly expand sales to EUR 102.4 million (previous ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The Marseille-Kliniken AG (prime standard, ISIN DE 0007783003, MKA) has successfully finalized a substantial sale-and-lease-back business with GE Commercial Finance. The Marseille-Kliniken AG ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) increased sales in the fiscal year 2003/04 by 5% to 200,1 million (previous year: 191.1 million). The earnings to DVFA/SG ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In the first three quarters of the fiscal year 2003/04, the Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) was able to further increase sales by 5.0% to EUR 150.3 million ...
